Related references
Note: Only part of the references are listed.Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting
Melanie B. Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The immunopharmaceutical effects and mechanisms of herb medicine
Chien-Fu Huang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2008)
Structure-activity relationship for inhibition of 5α-reductase by triterpenoids isolated from Ganoderma lucidum
Jie Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Ganoderma lucidum mycelia enhance innate immunity by activating NF-κB
MC Kuo et al.
JOURNAL OF ETHNOPHARMACOLOGY (2006)
Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
SH Park et al.
BMC CANCER (2006)
Ganoderma - A therapeutic fungal biofactory
R. Russell et al.
PHYTOCHEMISTRY (2006)
Effect of Fuzheng Yiliu decoction combined with chemotherapy on patients with intermediate and late stage gastrointestinal cancer
Bin Pan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Systemic therapy for advanced hepatocellular carcinoma: a review
AK Nowak et al.
EUROPEAN JOURNAL OF CANCER (2004)
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
JM Llovet et al.
HEPATOLOGY (2003)
Second-line chemotherapy with low-dose CPT-11 and cisplatin for colorectal cancer resistant to 5-FU-based chemotherapy
K Yoshimatsu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2003)
Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen)
E Boucher et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Chemical analysis of Radix Astragali (Huangqi) in China: A comparison with its adulterants and seasonal variations
XQ Ma et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2002)
Molecular mechanism of tumor necrosis factor-α production in 1→3-β-glucan (Zymosan)-activated macrophages
SH Young et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Normal human fibroblasts express pattern recognition receptors for fungal (1→3)-β-D-glucans
P Kougias et al.
INFECTION AND IMMUNITY (2001)
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells
K Takeda et al.
NATURE MEDICINE (2001)
Share Paper
